La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Pacira BioSciences Gestione
Gestione criteri di controllo 2/4
Pacira BioSciences' Il CEO è Frank Lee, nominato in Jan2024, ha un mandato di meno di un anno. possiede direttamente 0.23% delle azioni della società, per un valore di $ 1.39M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.9 anni e 4.9 anni.
Informazioni chiave
Frank Lee
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | less than a year |
| Proprietà del CEO | 0.02% |
| Durata media del management | 2.9yrs |
| Durata media del Consiglio di amministrazione | 4.9yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Little Excitement Around Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Revenues As Shares Take 29% Pounding
Jul 23
These 4 Measures Indicate That Pacira BioSciences (NASDAQ:PCRX) Is Using Debt Safely
Jun 07Pacira BioSciences, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
May 10Getting In Cheap On Pacira BioSciences, Inc. (NASDAQ:PCRX) Might Be Difficult
May 03Does Pacira BioSciences (NASDAQ:PCRX) Have A Healthy Balance Sheet?
Feb 05Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Low P/S No Reason For Excitement
Jan 05We Think Pacira BioSciences (NASDAQ:PCRX) Can Stay On Top Of Its Debt
Nov 03Is Pacira BioSciences (NASDAQ:PCRX) Using Too Much Debt?
Jul 28Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Intrinsic Value Is Potentially 26% Below Its Share Price
Jul 07Is Pacira BioSciences (NASDAQ:PCRX) A Risky Investment?
Apr 18We Think Pacira BioSciences (NASDAQ:PCRX) Can Stay On Top Of Its Debt
Dec 28Assessing Pacira BioSciences' Growth Prospects
Oct 20Pacira BioSciences guides Q3 revenue below consensus
Oct 13Pacira, Sevāredent team up to expand access to pain drug Exparel for dental procedures
Sep 27EMA panel backs expanding indication for Pacira's postsurgical pain treatment in kids
Sep 20Pacira BioSciences records 17.7% sequential growth in August revenue
Sep 13Pacira BioSciences provides update on July product sales
Aug 10Pacira BioSciences Q2 2022 Earnings Preview
Aug 02Pacira BioSciences sees Q2 revenue below consensus
Jul 14These 4 Measures Indicate That Pacira BioSciences (NASDAQ:PCRX) Is Using Debt Reasonably Well
Apr 04AMMINISTRATORE DELEGATO
Frank Lee (56 yo)
less than a year
Mandato
Mr. Frank D. Lee is Independent Director of Bausch Health Companies Inc. from May 14, 2024. Mr. Lee joined the Bausch Health Companies Inc. on May 14, 2024. He is an Adivsor at LSV Capital Management, LLC....
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chief Financial Officer | 8.3yrs | US$1.43m | 0.059% $ 380.9k | |
| Chief Operating Officer | 2.3yrs | US$1.53m | 0.028% $ 177.1k | |
| Chief Administrative Officer & Secretary | 9.8yrs | US$1.60m | 0% $ 0 | |
| Advisor | less than a year | US$6.88m | 0.51% $ 3.3m | |
| Chief Medical Officer | 3.1yrs | US$1.59m | 0.028% $ 180.3k | |
| CEO & Director | less than a year | Nessun dato | 0.018% $ 114.8k | |
| Principal Accounting Officer & Senior VP of Finance | 12.4yrs | US$288.82k | 0.0046% $ 29.7k | |
| Head of Investor Relations | no data | Nessun dato | Nessun dato | |
| Chief Legal & Compliance Officer | 2.7yrs | US$2.05m | 0.028% $ 178.9k | |
| Vice President of Human Resources | 9.1yrs | Nessun dato | Nessun dato | |
| Chief Manufacturing Officer | 1.3yrs | Nessun dato | Nessun dato |
2.9yrs
Durata media
52yo
Età media
Gestione esperta: Il team dirigenziale di PCRX è considerato esperto (durata media dell'incarico 2.9 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | less than a year | Nessun dato | 0.018% $ 114.8k | |
| Independent Director | 13.2yrs | US$364.01k | 0.025% $ 157.3k | |
| Chairman of the Board | 13.2yrs | US$390.51k | 0.016% $ 104.1k | |
| Independent Director | 17.7yrs | Nessun dato | Nessun dato | |
| Independent Director | 11.2yrs | US$373.01k | 0.043% $ 273.3k | |
| Independent Director | 4.9yrs | US$325.01k | 0.011% $ 73.1k | |
| Independent Director | less than a year | US$427.86k | 0% $ 0 | |
| Independent Director | less than a year | US$426.45k | 0.0074% $ 47.2k | |
| Independent Director | less than a year | US$427.16k | 0% $ 0 | |
| Independent Director | 7.2yrs | US$349.01k | 0.020% $ 128.4k | |
| Independent Director | less than a year | US$427.16k | 0.0043% $ 27.8k |
4.9yrs
Durata media
62.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PCRX sono considerati esperti (durata media dell'incarico 4.9 anni).